Trita Third Millennium is a knowledge-based pharmaceutical company that was established with the aim of innovating and developing Iran’s pharmaceutical industry. Along with this goal, the company focused on manufacturing the third generation of medicines (Nanomedicines) with improved efficacy, bioavailability and safety compared to conventional medicines. The three main parts of the company are manufacturing site, research and development (R&D) department, and business development department
The R&D department as a progressive unit has a mission of moving on the border of science, technology and innovation. This innovative unit has achieved unique formulation development at the country and region levels.
One of the most important projects of this company is the establishment of Trita Technology Institute which is an educational and research-based department relying on the international standard requirements of PIC/S.
The Zanjan manufacturing site was established with the aim of manufacturing knowledge-based products using nanotechnology following the EU-GMP standards.
Later, it was decided to set up and equip another manufacturing site near Tehran in Pardis Technology Park. In the implementation stages of this project, a consortium consisting of a European EPC contractor and the best local contractor companies used the highest standards of construction to design and build clean rooms meeting all global standard requirements.